Colorectal Cancer Prevention Quantity and Quality Count
|
|
- Marcia White
- 5 years ago
- Views:
Transcription
1 Colorectal Cancer Prevention Quantity and Quality Count Ernesto Drelichman, MD Gastrointestinal Surgery & Endoscopy Providence Hospital
2 Key Messages Colorectal cancer can be prevented Screening reduces mortality from CRC All persons aged 50 years or older should be screened High-risk individuals should begin screening earlier Several effective screening options are available; not screening is no longer an option
3 Key Messages Quality Risk Assessment Consent Screening Study with quality indicators Pathology Communication Computerized Registry Follow up
4 Colon & Rectal Cancer 2 nd leading cause of cancer death 3rd most common cancer overall 147,500 new cases annually 57,100 deaths annually
5 Why Screen?...the primary strategy for preventing colorectal cancer deaths is to detect and remove precancerous polyps or to detect and treat cancer in its earliest stages CDC 2/99
6 Colorectal Carcinogenesis Normal Mucosa Aberrant Crypt Foci Adenoma Cancer T(0) T(10)
7 Staging and Prognosis Stage TNM Grouping 5-Yr. Survival 0 Tis; N0; M0 100% I T1-2; N0; M % II T3-4; N0 M % III Any T; N1-3; M0 40% IV Any T; Any N; M1 5%
8 Colorectal Adenocarcinoma Flat Raised Ulcerated Infiltrating
9 Stage IV Colon Cancer
10 Diagnosis vs Screening People with symptoms or signs that suggest the presence of colorectal cancer or polyps fall outside the domain of screening and should be offered an appropriate diagnostic evaluation.
11 Presentation Proximal (R-side) Ill-defined abd. pain Weight loss Occult bleeding Distal (L-side) Altered bowel habits Dec. stool caliber BRBPR
12 Screening vs Surveillance Screening = Detection of asymptomatic disease in healthy individuals at average risk (e.g. no identifiable risk factors other than age) Surveillance = Search for asymptomatic disease among higher risk individuals (e.g. personal history of polyps or cancer, etc.)
13 Screening Compliance CRC Overall 53% Breast Cancer 77% Behavioral Risk Factor Surveillance System, 2001
14 Barriers to Screening Patient Lack of information Low perceived risk Inconvenience Discomfort Expense Provider Lack of information Competing priorities Too many options Access concerns Petersen GM - Gastroenterol Clin North Am 2002;31: Vernon SW - J Natl Cancer Inst 1997;89:
15
16 Katie s first colonoscopy "It really didn't hurt"
17 Screening Options Interval Fecal occult blood test (FOBT) 1 year Flexible sigmoidoscopy 5 years FOBT/Flex. Sig. 1 year/5 years Barium enema (DCBE) 5 years Colonoscopy 10 years Choice of screening tests should be suited to the situation.
18 IDEAL SCREENING TEST Detect all curable cancers Detect and allows excision adenomas Available, acceptable, safe Affordable and cost effective Providers must tailor to patients
19 FOBT Detect the pseudoperoxidase activity of heme Sensitivity neoplasms = 15% to 30% Poor specificity and high false positives
20 A better FIT Noninvasiveness No prep No diet restrictions Sensitivities of 66% for detecting cancer and 27% for detecting advanced polyps and a specificity of 95% Cost $18 and $30 Medicare reimbursed Morikawa T et al Gastroenterology. 2005;129:422-8
21 DNA Detect gene mutations in tumor cells sloughed into stool Noninvasiveness No prep No diet restrictions
22 DNA The DNA panel Sensitivity for invasive cancers = 40.8% Hemoccult P<0.001 = 14.1 percent Expensive Imeriale et al. N Engl J Med. 2004;351:
23 Barium Enema Screening No sedation required Reasonable sensitivity for cancer (83%) 1 1 Rex, et al. - Gastroenterology 1997;112:17-23; 2 Winawer, et al. - N Engl J Med 2000 Jun 15;342(24):
24 Barium Enema Screening Low Specificity - frequent need for repeat bowel prep and colonoscopy Lipoma Large fold Residual stool Poor sensitivity for polyps > 10 mm (48%) 2 1 Rex, et al. - Gastroenterology 1997;112:17-23; 2 Winawer, et al. - N Engl J Med 2000 Jun 15;342(24):
25 Virtual Colonoscopy Lack of consensus about its role in screening. Sensitivity 60% for cancer detection
26 SCREENING COLONOSCOPY If the result of a screening test is abnormal, physicians should recommend a complete colonic Evaluation: Colonoscopy Ko, Hyman Dis Colon Rectum 2006; 49: 1 3
27 COLONOSCOPY SCREENING IN THE U.S. Recommended as an option in 1997 Proposed as the preferred method of screening by ACG in 2000 Reimbursement by Medicare in 2001
28 Advantages Colonoscopy Gold Standard for Quality Highest sensitivity and specificity Entire colorectum assessed Neoplasms can be biopsied and/or removed during the screening exam (no follow-up testing required)
29
30
31
32
33 How to bend light?
34
35 Prototype Fiberscope
36 Basil Hirschowitz, MD Emeritus Professor UAB
37 Basil Hirschowitz, M.D
38
39
40
41 Quality Screening Study Risk Assessment Uses and documents quality indicators in report Avoids potential complications of exam Makes correct recommendations in report Communicates to patients and referring physicians Registry to assure follow up
42 Perianal and DRE Photograph IC Valve appendiceal orifice Describe Prep Extraction time >6min Recommendations/risk Letter to referral Communicate to patient Computerized Registry Quality Indicators for Colonoscopy
43 A Quality exam starts here Perianal Exam and DRE
44
45 Terminal Ileum
46
47
48 Complete Study No cecal intubation Why and how was study completed what were the results Ileocolonic anastomosis Landmarks Appendiceal orifice Ileocecal valve Terminal ileum Transabdominal illumination*
49 Transillumination The Light at the End of the Tunnel
50 Diverticulosis Tics
51
52 Pedunculated Polyp Excision
53 Identification and removal of polyps prevents colorectal cancer
54 Piece-meal Polypectomy
55 Transanal Endoscopic Microsurgery
56 Direct Drive Endoscopy
57
58 Location, Location, Location Ink
59 Laparoscopic Colectomy
60 Informed Consent Perforation 1 of 1000 Major hemorrhage 3 of 1000 Respiratory depression 5 of 1000 Death from complication 3 of 10,000 Multiple series of prospective studies
61 Quality Perform a Safe Exam Good Risk Assessment Preop Appropriate study Cardiac and pulmonary monitors Complete hemostasis Avoid excessive looping Be aware of depth during polepectomy Admit high risk patient and obtain labs and dx studies
62 Know when to say Uncle Order BE to complete study
63 Know how to identify a complication
64 Know how to correct a complication Perforation
65 Know how to identify a Complication
66 Splenic injury
67 Key Messages Risk Assessment FAMILIAL RISK OF CRC Familial Setting Lifetime Risk General population in U.S. 6% 1 First degree relative CRC 2-3 x 2 first degree relative 3-4 x First degree CRC < x AGA. Gastroent 2003; 124:544
68 High Risk Individuals Amsterdam Criteria (AC I,II) 3 relatives with CRC w 1 being a 1st degree relative of other 2 successive generations 1 CRC onset < 50 yrs of age AC II: substitute other HNPCC related CRC
69 Familial Colorectal Cancers HNPCC lifetime risk CRC 80-85% proximal to splenic flexure Extracolonic Cancers endometrial Ca- 60% ovarian Ca, UGI tumors GU cancers biliary and pancreatic tumors Risk of 2nd malignancy 50% in 15 years
70 Screening Recommendations Site Procedure Lower age limit Interval (years) (years) Colon Colonoscopy Endometrium/ovaries GYN exam, CA Transvaginal U/S Stomach Gastroscopy Urinary tract U/S, urine cytology Thorson AG Dis Colon Rectum 1999;42:1-9
71 Colon Cancer in HNPCC Surgeons Approach Surgical Options (+ Malignancy): 1. Total Colectomy with Ileorectal Anastomosis 2. Segmental Colectomy 3. Proctocolectomy +/- IPAA (+/- Prophylactic TAH, BSO) Cancer Prevention and Quality of Life
72 Polyposis Syndromes of the Colon Neoplastic Syndromes Familial Adenomatous Polyposis Attenuated Adenomatous Polyposis
73 FAP APC (5q21) 1 in 5,000 persons > 100 CR adenomas UGI polyps, osteomas, extra teeth Extracolonic cancers: - periampullary
74 FAP-Clinical Presentation
75 FAP - Colon
76 Gardner s Syndrome AD - subtype of FAP Additional features: - CHRPEs - desmoids, epidermoid cysts, fibromas, lipomas Extracolonic cancers: - thyroid, adrenal, HB Multifocal CHRPE Image courtesy of Dr. N. Lindor, Mayo Clinic Rochester
77 CT Scan Abdomen and Pelvis
78 Ulcerative Colitis and Crohn s Colitis
79 RISK OF COLORECTAL CANCER
80 Surveillance Colonoscopy should begin at 8-10 years duration of disease Then at 1-2 year intervals Exam full colonoscopy and 2-4 random biopsy samples at 10cm intervals along entire length of colon Eaden J et al. Gastrointestinal Endoscopy 2000
81 SURVEILLANCE BIOPSY PROTOCOL
82 PSEUDOPOLYPS
83 DALMS IN ULCERATIVE COLITIS
84 Risk of Cancer associated with Dysplasia Review of ten prospective studies Probability of cancer DALM 43% HGD 42% LGD 19% Bernstein et al. Lancet 1994
85 Surveillance Problems Questionnaire sent to GI (UK) Only 35% maintain a registry and only 49% of these were computerized Only 53% advised colectomy with HGD Only 4% for LGD Eaden J et al. Gastrointestinal Endoscopy 2000
86 Vosser
87 Vosser
88 SURGICAL OPTIONS IN ULCERATIVE COLITIS
89
90
91 Pathology Endo Path 24 hours What to do with results
92 Key Messages Communication recommendations Computerized Registry Follow up
93 nccn.org
94 Current Guidelines High Risk Average Risk Family Hx Personal Hx Age < 50 Age > 50 Heritable No Defined Syndrome Syndrome CRN IBD Screen Later Screen Now* Screen Early Screen Early Surveillance Colonoscopy Colonoscopy if Positive * Multiple options
95 Report Quality Indicators
96 Key Messages Colorectal cancer can be prevented Screening reduces mortality from CRC All persons aged 50 years or older should be screened High-risk individuals should begin screening earlier Several effective screening options are available; not screening is no longer an option
97 Key Messages Quality Study Risk Assessment Consent Safe Screening Study, dictated and photodocument Pathology and localization Communication Computerized Registry Follow up know what to do with results
98 GI Surgery and Endoscopy MISSION To Prevent colorectal cancer and its impact through education, risk assessment, screening and surveillance ENDO (3636)
Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow
Colon Cancer Screening & Surveillance Amit Patel, MD PGY-4 GI Fellow Epidemiology CRC incidence and mortality rates vary markedly around the world. Globally, CRC is the third most commonly diagnosed cancer
More informationColon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership
Colon Screening in 2014 Offering Patients a Choice Clark A Harrison MD The Nevada Colon Cancer Partnership Objectives 1. Understand the incidence and mortality rates for CRC in the US. 2. Understand risk
More information2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)
Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,
More informationColorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi
Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change
More informationEARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC
Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER Epidemiology of CRC Colorectal cancer (CRC) is a common and lethal disease Environmental
More informationScreening & Surveillance Guidelines
Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following
More informationRazvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER
Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER Epidemiology of CRC Colorectal cancer (CRC) is a common and lethal disease Environmental
More informationCLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING
CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace
More informationQuality Measures In Colonoscopy: Why Should I Care?
Quality Measures In Colonoscopy: Why Should I Care? David Greenwald, MD, FASGE Professor of Clinical Medicine Albert Einstein College of Medicine Montefiore Medical Center Bronx, New York ACG/ASGE Best
More informationColorectal Cancer Screening: A Clinical Update
11:05 11:45am Colorectal Cancer Screening: A Clinical Update SPEAKER Kevin A. Ghassemi, MD Presenter Disclosure Information The following relationships exist related to this presentation: Kevin A. Ghassemi,
More informationLatest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population
Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population David T. Rubin, M.D. Assistant Professor of Medicine Inflammatory Bowel Disease Center MacLean Center for Clinical Medical Ethics
More informationCRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC
10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationNeoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012
Neoplastic Colon Polyps Joyce Au SUNY Downstate Grand Rounds, October 18, 2012 CASE 55M with Hepatitis C, COPD (FEV1=45%), s/p vasectomy, knee surgery Meds: albuterol, flunisolide, mometasone, tiotropium
More informationColon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011
Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected
More informationFamilial Adenomatous Polyposis
Familial Adenomatous Polyposis 1 in 10,000 incidence 100 s to 1000 s of colonic adenomas by teens Cancer risk: colon, gastric, duodenum (periampulla), small bowel, pancreas, papillary thyroid, childhood
More informationGENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department
GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY
More informationCENTERS FOR DISEASE CONTROL AND PREVENTION CENTERS FOR DISEASE CONTROL AND PREVENTION. Incidence Male. Incidence Female.
A Call to Action: Prevention and Early Detection of Colorectal Cancer (CRC) 5 Key Messages Screening reduces mortality from CRC All persons aged 50 years and older should begin regular screening High-risk
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationAlberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines
Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background... 3 Terms, Definitions
More informationColorectal Cancer: Screening & Surveillance
Objectives Colorectal Cancer: Screening & Surveillance Chanda K. Ho, MD MPH Advances in Internal Medicine Brief overview epidemiology and pathogenesis of colorectal cancer (CRC) To review screening modalities
More informationMeasure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: The
More information11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist
Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,
More informationColorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005
Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of
More informationPathology reports, related operative reports and consult letters must be provided with a request for assessment.
Page 1 of 6 Polyposis Syndromes Inherited risk for colorectal cancer is associated with a number of polyposis syndromes (genes), some of which are well-defined and others are less common. Identification
More informationObjectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background
Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy
More informationOPEN ACCESS TEXTBOOK OF GENERAL SURGERY
OPEN ACCESS TEXTBOOK OF GENERAL SURGERY COLORECTAL POLYPS P Goldberg POLYP A polyp is a localised elevated lesion arising from a epithelial surface. If it has a stalk it is called a pedunculated polyp
More informationcolorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018
colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast
More informationPage 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis
Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center
More informationUpdates in Colorectal Cancer Screening & Prevention
Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University
More informationPENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)
Stage I: Binning Dashboard GENE/GENE PANEL: APC ACTIONABILITY 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does the practice guideline
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationFinancial Disclosers
Slide 1 Colorectal Cancer Screening Jason Hemming, MD NESGNA November 15, 2014 Slide 2 Bio Slide 3 Financial Disclosers I have no actual or potential conflict of interest relation to this presentation
More informationGeneral and Colonoscopy Data Collection Form
Identifier: Sociodemographic Information Type: Zip Code: Inpatient Outpatient Birth Date: m m d d y y y y Gender: Height: (inches) Male Female Ethnicity: Weight: (pounds) African American White, Non-Hispanic
More informationWellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer
Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer Healthy Habits and Cancer Screening Rev 10.20.15 Page
More informationDavid P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH
Colon Cancer 2015 David P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH Colon Cancer Case presentation 72yo woman presented 1/03 abd discomfort and nausea Found to have
More informationMeasure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: The rate of screening
More informationColorectal cancer screening: Is total prevention possible?
Just the facts colorectal cancer Colorectal cancer screening: Is total prevention possible? Jeffrey Fox, MD, MPH Concepts and Controversies 2011 2010 NCI estimates for US: 142, 570 new CRC diagnoses 51,370
More informationCANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital
CANCER SCREENING Er Chaozer Department of General Medicine, Tan Tock Seng Hospital Introduction Screening average risk patients Benefits and harms from screening Early cancer detection early treatment
More informationClassification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes
Hereditary polyposis syndromes Classification of polyposis syndromes two major groups adenomatous and non-adenomatous polyposis syndromes Adenomatous polyposis syndromes Familial adenomatous polyposis(fap)
More informationClinical UM Guideline
Subject: Guideline #: Current Effective Date: 06/28/2016 Status: Revised Last Review Date: 05/05/2016 Description This document addresses colonoscopy, an endoscopic procedure which allows direct visual
More informationCOLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University
COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS What is CRC? CRC (CRC) is cancer of the large intestine (colon), the lower part of the digestive system. Rectal cancer is cancer of the last several inches of the colon. Together,
More informationLIST OF ABBREVIATIONS
Gastroenter oenterology 2005 Royal College of Physicians of Edinburgh Screening and surveillance for upper and lower gastrointestinal cancer JN Plevris Consultant Gastroenterologist and Honorary Senior
More informationQuality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Efficiency DESCRIPTION:
More informationA Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD
A Trip Through the GI Tract: Common GI Diseases and Complaints Jennifer Curtis, MD Colon Cancer How does it develop? Most cancers arise from polyps Over time these can turn into cancer Combination of genetic
More informationHistorical. Note: The parenthetical numbers in the Clinical Indications section refer to the source documents cited in the References Section below.
Clinical UM Guideline Subject: Colonoscopy Guideline #: CG-SURG-01 Current Effective Date: 01/21/2015 Status: Revised Last Review Date: 05/15/2014 Description Colonoscopy describes the direct visual inspection
More informationGuidelines for Breast, Cervical and Colorectal Cancer Screening
Guidelines for Breast, Cervical and Colorectal Cancer Screening Your recommendation counts. Talk to your patients about screening for cancer. CancerCare Manitoba provides organized, population-based screening
More informationColorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital
Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd
More informationColorectal Cancer Screening
Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer Colorectal Cancer Screening Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson
More informationThe New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Colorectal cancer: colonoscopic surveillance for prevention of colorectal cancer in patients with ulcerative colitis, Crohn
More informationColorectal Cancer Screening. Paul Berg MD
Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order
More informationColorectal Cancer Screening What are my options?
069-Colorectal cancer (Rosen) 1/23/04 12:59 PM Page 69 What are my options? Wayne Rosen, MD, FRCSC As presented at the 37th Annual Mackid Symposium: Cancer Care in the Community (May 22, 2003) There are
More informationColon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4
Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed
More informationThis is the portion of the intestine which lies between the small intestine and the outlet (Anus).
THE COLON This is the portion of the intestine which lies between the small intestine and the outlet (Anus). 3 4 5 This part is responsible for formation of stool. The large intestine (colon- coloured
More informationDysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background
SCENIC: Polypoid in UC Definition How do I practice for Surveillance of Colitis? Themos Dassopoulos, M.D. Director, BSW Center for IBD Themistocles.Dassopoulos@BSWHealth.org Tel: 469-800-7189 Cell: 314-686-2623
More informationACG Clinical Guideline: Colorectal Cancer Screening
ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,
More informationGI CANCER SCREENING- Is It Worth It? Sylvia M. Oats, MSN, APRN, ANP-BC Susan H. Miedecke, MSN, APRN, FNP-BC Gastroenterology Clinic of Acadiana
GI CANCER SCREENING- Is It Worth It? Sylvia M. Oats, MSN, APRN, ANP-BC Susan H. Miedecke, MSN, APRN, FNP-BC Gastroenterology Clinic of Acadiana Life is a sexually transmitted disease, and the mortality
More informationWhat Questions Should You Ask?
? Your Doctor Has Ordered a Colonoscopy. What Questions Should You sk? From the merican College of Gastroenterology www.acg.gi.org Normal colon Is the doctor performing your colonoscopy a Gastroenterologist?
More informationColorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users
Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health
More informationPrevention of Bowel Cancer: which patients do I send for colonoscopy?
Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London
More informationSummary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4):
Rep Pract Oncol Radiother, 2007; 12(4): 201-206 Original Paper Received: 2006.12.19 Accepted: 2007.04.02 Published: 2007.08.31 Authors Contribution: A Study Design B Data Collection C Statistical Analysis
More informationColorectal Cancer Screening
Scan for mobile link. Colorectal Cancer Screening What is colorectal cancer screening? Screening examinations are tests performed to identify disease in individuals who lack any signs or symptoms. The
More informationNavigators Lead the Way
RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and
More informationContent. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome
of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines
More informationColorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers
Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in
More informationJoint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.
Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,
More informationColorectal Cancer in 2006: New Developments
James J. Stark, MD Colorectal Cancer in 2006: New Developments Melissa Bennett, MS, CGC Myriad Genetic Laboratories Thomas Duntemann,, MD Ray Ramirez, Jr., MD Hereditary Colon Cancer and Genetic Testing
More informationFor identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013
For identification, support and follow up related to Familial Gastrointestinal Cancer conditions South Island Cancer Nurses Network September 2013 Who are we? Specialist multidisciplinary team: Nurse coordinators,
More informationGENERAL COLORECTAL CANCER INFORMATION. What is colorectal cancer?
GENERAL COLORECTAL CANCER INFORMATION What is colorectal cancer? Colorectal cancer is cancer that develops in the colon or the rectum. The colon and rectum are parts of the digestive system, which is also
More informationCancer Genomics 101. BCCCP 2015 Annual Meeting
Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic
More information10/25/2011 OBJECTIVES Cancer Screening in the United States, 2011 A Review of Current American Cancer Society Guidelines and Issues in Cancer Screenin
OBJECTIVES Cancer Screening in the United States, 2011 A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening Kathy Gray, DNP, CRNP, FNP-BC Cancer Screenings and Guidelines
More informationBowel cancer screening and prevention
Bowel cancer screening and prevention Cancer Incidence and Mortality Victoria 2012 Number 6000 5000 4000 3000 2000 Incidences = 29,387 Mortality = 10,780 Incidence Mortality 1000 0 Prostate Breast Bowel
More informationColonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient
Colonoscopy Policy Number: Original Effective Date: MM.12.003 12/01/2010 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient
More informationColon, or Colorectal, Cancer Information
Colon, or Colorectal, Cancer Information Definition Colon, or colorectal, cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon). Other types of cancer can affect
More informationColorectal Cancer Screening and Surveillance
Medical Coverage Policy Effective Date...10/15/2017 Next Review Date...10/15/2018 Coverage Policy Number... 0148 Colorectal Cancer Screening and Surveillance Table of Contents Related Coverage Resources
More informationEarly detection and screening for colorectal neoplasia
Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.
More informationHow to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov R. Sáenz, FACG,FASGE
How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov 11 2017 R. Sáenz, FACG,FASGE Wheel has been discovered already Policy Planning Thanks to GBD Big Data CRC
More informationColorectal Cancer Screening and Surveillance
1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal
More informationEndoscopic techniques for surveillance and treatment of FAP
Endoscopic techniques for surveillance and treatment of FAP Evelien Dekker MD PhD Department of Gastroenterology & Hepatology Academic Medical Center Amsterdam The Netherlands FAP: endoscopic surveillance
More informationDetection of Colorectal Neoplasms in Asymptomatic Patients
Detection of Colorectal Neoplasms in Asymptomatic Patients Scope This guideline provides recommendations for the detection of colorectal cancer and adenomas in asymptomatic patients. These recommendations
More informationImproving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)
Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More informationSurveying the Colon; Polyps and Advances in Polypectomy
Surveying the Colon; Polyps and Advances in Polypectomy Educational Objectives Identify classifications of polyps Describe several types of polyps Verbalize rationale for polypectomy Identify risk factors
More information1101 First Colonial Road, Suite 300, Virginia Beach, VA Phone (757) Fax (757)
1101 First Colonial Road, Suite 300, Virginia Beach, VA 23454 www.vbgastro.com Phone (757) 481-4817 Fax (757) 481-7138 1150 Glen Mitchell Drive, Suite 208 Virginia Beach, VA 23456 www.vbgastro.com Phone
More informationPage 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!
Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!
More informationMr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer
Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth
More informationDIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae
ENDOSCOPY Z50 Duodenoscopy (not to be claimed if Z399 and/or Z00 performed on same patient within 3 months)... 92.10 Z9 Subsequent procedure (within three months following previous endoscopic procedure)...
More informationWellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview
Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview Cancer Types Rev. 10.20.15 Page 35 Colorectal Cancer Overview Group Discussion True False Not
More informationremoval of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2
Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance
More information2012 update. Bowel Cancer. Information for people at increased risk of bowel cancer. Published by the New Zealand Guidelines Group
2012 update Bowel Cancer Information for people at increased risk of bowel cancer Published by the New Zealand Guidelines Group i Contents Introduction 1 The bowel 1 Bowel cancer 3 What are the symptoms
More informationHereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD
Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Living Beyond Cancer A-Z January 12,2019 Hereditary CRC Syndromes Objectives are to discuss the : Most common Hereditary CRC syndromes
More informationFECAL OCCULT BLOOD TEST
MEDICAL POLICY For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS FECAL OCCULT BLOOD TEST Policy Number: CMP - 023 Effective Date: January 1, 2018 Table
More informationCASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD
CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD Disclosure Statement NKC: No relevant conflicts to disclose. DTR: No relevant
More informationStructured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007
Structured Follow-Up after Colorectal Cancer Resection: Overrated R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007 Guidelines for Colonoscopy Production: Surveillance US Multi-Society
More informationPatologia sistematica V Gastroenterologia Prof. Stefano Fiorucci. Colon polyps. Colorectal cancer
Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci Colon polyps Colorectal cancer Harrison s Principles of Internal Medicine 18 Ed. 2012 Colorectal cancer 70% Colorectal cancer CRC and colon
More informationGUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY
Position Statement produced by BSG, AUGIS and ACPGBI GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Introduction In 2011 the Independent Practice
More information